Sakir Mutevelic M.D.

Sakir Mutevelic MD, MSc is an accomplished healthcare executive with extensive experience in oncology and medical affairs. Currently serving as the Chief Medical Officer at Curium Pharma since November 2021, Sakir has previously held significant leadership roles, including Global Oncology Clinical Development Program Lead at Novartis and Global Oncology Early Products Strategy Head at Servier. Additional positions include Global Oncology New Products Strategy Head at Shire and Head of EMEA Medical Information at Baxalta. Sakir's career at Baxter International Inc. included leading Hematology Global Program & Portfolio Management, while earlier roles at Boehringer Ingelheim encompassed various leadership positions in oncology and thrombosis. Sakir holds an MD and MSc in Pharmacology from a Medical University and an Executive General Management Certificate from the Austria Federal Chamber of Commerce, along with a Project Management Professional designation from the Project Management Institute.